Press release
Peripheral Neuropathy Treatment Market Forecast to Hit USD 1.14B
The peripheral neuropathy treatment market is expanding steadily as global awareness, diagnostic accuracy, and treatment accessibility continue to improve. Peripheral neuropathy, a condition caused by damage to the peripheral nervous system, affects millions worldwide-most commonly individuals living with diabetes, autoimmune disorders, infections, vitamin deficiencies, and chemotherapy-related nerve damage. With chronic diseases rising sharply, the demand for effective treatment options-both pharmacological and non-pharmacological-has never been higher.
In 2025, the global peripheral neuropathy treatment market achieved a value of USD 792.55 Million. The market is forecast to rise at a CAGR of 3.70% during 2026-2035, ultimately reaching USD 1139.76 Million by 2035. This steady growth is supported by an aging global population, a rising incidence of diabetes, improved healthcare infrastructure, and increasing clinical focus on nerve pain management.
This in-depth analysis examines key market drivers, treatment categories, technological advancements, therapeutic adoption trends, regional patterns, and major players shaping the industry's competitive landscape.
Get a Free Sample Report with Table of Contents - https://www.expertmarketresearch.com/reports/peripheral-neuropathy-treatment-market/requestsample.
Understanding the Peripheral Neuropathy Treatment Market
Peripheral neuropathy occurs when nerves outside the brain and spinal cord are damaged. The result can include pain, tingling, numbness, hypersensitivity, muscle weakness, or autonomic dysfunction. Treatment varies depending on the underlying cause, severity, symptom pattern, and patient health profile.
Across the global healthcare ecosystem, rising public awareness and early diagnosis are driving demand for:
Advanced pain management therapies
Safer pharmacological options
Long-term disease management solutions
Non-pharmacological therapies with fewer side effects
Home-based neuromodulation devices
Healthcare systems are increasingly integrating multimodal treatment pathways, combining medications with rehabilitation, electrical stimulation therapies, and lifestyle interventions.
Key Market Drivers Supporting Global Growth
1. Rising Prevalence of Diabetes
Diabetes remains the leading cause of peripheral neuropathy. Over 50% of long-term diabetes patients develop neuropathy symptoms, contributing significantly to market expansion. With diabetes cases projected to exceed 640 million people by 2030, demand for neuropathy care is increasing across hospitals and outpatient clinics.
2. Growing Incidence of Chemotherapy-Induced Neuropathy
As global cancer survival improves, chemotherapy-induced peripheral neuropathy (CIPN) has become a leading complication of cancer treatment. This trend fuels demand for:
Pain management medications
Nerve-protective pharmaceuticals
Rehabilitative neuromodulation devices
3. Wider Availability of Diagnostic Tools
Improved access to nerve conduction studies, quantitative sensory testing, and advanced imaging enhances early diagnosis and treatment adoption.
4. Increase in Government Healthcare Support
Healthcare programs promoting chronic disease management-especially diabetes, HIV, and cancer-indirectly expand the neuropathy treatment market.
5. Growing Use of Combination Therapies
Healthcare providers are moving toward integrated treatment plans such as:
Pharmacological + TENS therapy
Pain relievers + antidepressants
Plasma exchange for autoimmune neuropathies
Peripheral Neuropathy Treatment Market Breakdown
Market Breakup by Type
1. Diabetic Peripheral Neuropathy
The largest segment, driven by global diabetes prevalence. Growing primary care screening programs support early identification and management.
2. Chemotherapy-Induced Peripheral Neuropathy
Increased cancer treatment rates, particularly with neurotoxic drugs like taxanes, platinum compounds, and vinca alkaloids, contribute to rapid segment growth.
3. Idiopathic Peripheral Neuropathy
A significant portion remains classified as idiopathic, typically associated with age-related nerve degeneration.
4. HIV/AIDS-Associated Neuropathy
Antiretroviral therapy (ART)-induced neuropathy and infection-linked nerve damage remain concerns in developing regions.
Market Breakup by Treatment Method
Pharmacological Therapies
Pain Relievers
These include OTC medications and prescription-strength analgesics. While widely used, they primarily offer short-term relief.
Anti-Seizure Medications
Drugs such as gabapentin and pregabalin are commonly prescribed for neuropathic pain due to their impact on nerve signaling.
Anti-Depressants
Tricyclic antidepressants and SNRIs help reduce neuropathic pain by modulating serotonin and norepinephrine pathways.
Non-Pharmacological Therapies
Transcutaneous Electrical Nerve Stimulation (TENS)
An increasingly popular alternative, providing pain reduction through nerve modulation.
Plasma Exchange
Used for immune-mediated neuropathies such as Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy (CIDP).
Others
Includes physiotherapy, acupuncture, and laser therapy, all gaining acceptance as adjunctive treatments.
Read the Full Report with the Table of Contents - https://www.expertmarketresearch.com/reports/peripheral-neuropathy-treatment-market.
Market Breakup by End User
Hospitals and Clinics
Remain the primary setting for diagnosis and treatment initiation.
Retail Pharmacy
A fast-growing channel due to high availability of OTC medications and long-term therapy requirements.
Online Pharmacy
Witnessing rapid growth due to convenience, privacy, and rising digital healthcare adoption.
Market Breakup by Treatment Channel
Public Sector
Large patient volume, government-sponsored healthcare plans, and public awareness campaigns support market growth.
Private Sector
Faster adoption of advanced therapies, premium treatment options, and wider availability of innovative devices.
Market Breakup by Region
North America
Leading market with strong awareness, robust insurance coverage, and advanced clinical infrastructure.
Europe
Strong focus on chronic disease management, early diagnosis, and improved access to specialty care.
Asia Pacific
The fastest-growing region, driven by rising diabetes cases, expanding healthcare spending, and increased clinical research.
Latin America
Moderate growth supported by improved access to public healthcare programs.
Middle East and Africa
Gradual market improvement due to increased investments in non-communicable disease management.
Competitive Landscape: Leading Companies
Major players actively shaping the market include:
Abbott Laboratories
Bristol Myers Squibb Co
Novartis AG
Eli Lilly and Company
Pfizer Inc.
GlaxoSmithKline Plc
Merck and Co. Inc.
F. Hoffmann-La Roche Ltd
Cipla Ltd.
Lupin Ltd
Dr. Reddy's Laboratories
RxFunction, Inc.
These companies are investing in new formulations, neuromodulation devices, and combination therapies aimed at improving long-term outcomes.
Future Outlook of the Peripheral Neuropathy Treatment Market
1. Expansion of Personalized Medicine
Tailored treatment plans based on patient genetics, disease severity, and nerve damage patterns are gaining traction.
2. Rising Adoption of Medical Wearables
Smart devices for nerve stimulation and gait improvement are becoming central to long-term neuropathy management.
3. Growth in Homecare Settings
Home-based therapies such as wearable neuromodulation devices and online prescription renewals support rising demand.
4. Advancements in Regenerative Therapies
Stem cell treatments, nerve growth factor agents, and biologics are being explored in clinical trials.
5. Continued Growth in Digital Health
AI-assisted diagnostics and remote care platforms will enhance early detection and monitoring.
Find More Reports
India Disposable Medical Gloves Market - https://bit.ly/3lu8TC1.
India Hospital Beds Market - https://bit.ly/3MlzkdT.
India Insulin Pumps Market - https://bit.ly/444jqe2.
India Medical Gases Market - https://bit.ly/48R1QvN.
Media Contact
Company Name: Claight Corporation
Contact Person: Roshan Kumar, Business Consultant
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com
About Us
Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.
Our high-quality, data-driven analysis provides the essential framework for organizations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organization remains agile, proactive, and poised for success in today's competitive market.
Don't miss the opportunity to elevate your business intelligence and strengthen your strategic planning. Secure your organization's future success by acquiring one of our Expert Market Research reports today.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Peripheral Neuropathy Treatment Market Forecast to Hit USD 1.14B here
News-ID: 4309651 • Views: …
More Releases from Expert Market Research
Global POC Diagnostic Market Set to Grow at 8.50% CAGR
How Is the Point-of-Care (POC) Diagnostic Market Transforming Global Healthcare Delivery?
The Point-of-Care (POC) diagnostic market has become one of the most transformative segments in modern healthcare. As healthcare systems shift toward faster, more accessible, and decentralized testing methods, POC diagnostics play a central role in enabling rapid clinical decision-making. From glucose testing and infectious disease screening to cancer marker detection and cardiac monitoring, POC devices empower healthcare providers and patients…
Textile Dyes Market Analysis - Size, Trends, Growth, and Forecast (2026-2035)
The textile dyes market is anticipated to reach USD 19.43 billion by 2035, growing from USD 10.75 billion in 2025. The market is projected to expand at a compound annual growth rate (CAGR) of 6.10% from 2026 to 2035. This growth is driven by the increasing demand for colored textiles across various industries, including fashion, home furnishings, and automotive. In this blog, we will explore the textile dyes market's overview,…
Oxygen Therapy Market Forecast to Grow at 6.83% CAGR by 2035
What is driving the growth of the Oxygen Therapy Market globally?
Oxygen therapy is a medical intervention that delivers supplemental oxygen to patients suffering from respiratory disorders or other conditions that compromise oxygen levels in the blood. The global demand for oxygen therapy has grown significantly due to increasing incidences of chronic respiratory diseases, rising geriatric populations, and favorable government incentives supporting oxygen therapy devices.
The global oxygen therapy market was valued…
Global Osteoarthritis Therapeutics Market to Hit USD 22.85Bn by 2035
What is driving the growth of the Osteoarthritis Therapeutics Market and how is it evolving globally?
Osteoarthritis (OA) is a degenerative joint disease characterized by the gradual breakdown of cartilage, leading to pain, stiffness, and limited mobility. The rising prevalence of OA globally, especially among the aging population, has made the osteoarthritis therapeutics market a critical segment in musculoskeletal healthcare. Patients are increasingly seeking therapies that reduce pain, improve joint function,…
More Releases for Peripheral
Key Trends Reshaping the Peripheral Arterial Disease Market: Innovative Shockwav …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Peripheral Arterial Disease Market Size Growth Forecast: What to Expect by 2025?
The overall valuation of the peripheral arterial disease sector has seen substantial expansion lately, projected to climb from $4.36 billion recorded in 2024 to reach $4.74 billion by 2025, reflecting an 8.7% compound annual growth rate over…
Peripheral Stent Market - Pioneering Solutions for Peripheral Artery Disease: Re …
Newark, New Castle, USA - Growth Plus Reports has published a new report on Peripheral Stent Market, which includes a detailed analysis based on competitors and important market segments (2023-2031). The Global Peripheral Stent provides a thorough analysis of many segments such as opportunities, market size, developments, innovation, sales, and overall growth of leading players. The research is based on primary and secondary statistical data, and it includes both intuitive…
Peripheral Vascular Devices Market - Empowering Mobility, Preserving Health: Ele …
Newark, New Castle, USA - new report, titled Peripheral Vascular Devices Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Peripheral Vascular Devices market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Peripheral Vascular Devices market. The report offers an overview of…
Peripheral Vascular Devices Market Report 2018: Segmentation by Types (Periphera …
Global Peripheral Vascular Devices market research report provides company profile for Abbott Vascular, Bayer Healthcare, Volcano Corporation, Teleflex Medical and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The report also provides detailed segmentation…
Peripheral Vascular Device Market Size, Peripheral Vascular Device Market Share, …
Global Peripheral Vascular Device Market Size is observed to gain traction owing to the factors such as increasing research and development for developing several new product, and rising funding by the private organizations.
Request for Sample of This Research Report @ https://bit.ly/2xjOKpC
Top Key Player:-
Abbott Laboratories
Braun Melsungen AG
Boston Scientific Corporation
R. Brad, Inc.
Cardinal Health, Inc.
Medtronic plc.
Cook Medical, Inc.
Teruma Corporation
Jude Medical, Inc.
The Spectranetics Corporation
Volcano Corporation
Peripheral vascular disorder (PVD) is a blood circulation disorder…
Peripheral Artery Disease Market By Type (Peripheral Angioplasty Balloons, Perip …
Peripheral artery disease is characterized by plaque built up in the arteries carrying blood from heart to legs, arms, and other limbs. Peripheral artery disease in turn also increases the risk of other cardiovascular disorders such as heart attack, coronary heart disease, stroke, and ischemic attack.
Request Sample At: https://www.bigmarketresearch.com/request-sample/1633533
The global peripheral artery disease market generated $3,136 million in 2016, and is projected to reach $4,980 million by 2023, registering a…
